News Archives

Members can now view all performance category webinars for the MIPS 2025 Performance Year, available at www.apma.org/mipswebinars.

APMA is thrilled to announce that six components will receive 2025 Center for Professional Advocacy (CPA) Financial Assistance Grants. These grants are an important part of APMA’s scope-of-practice initiatives, which include the Innovation Grant program.

On Monday, APMA submitted comments to CMS on the Advance Notice of Methodological Changes for Calendar Year (CY) 2026 for Medicare Advantage (MA) Capitation Rates and Part C and Part D Payment Policies.

Check out these two exciting writing competitions for podiatric students, residents, and fellows—one focusing on physician well-being and financial literacy, the other on general podiatric topics—that offer great prizes and recognition. Don’t miss out!

CMS has announced that an automatic MIPS exception will be applied to MIPS eligible clinicians in designated counties of California in response to recent wildfires.

Are you a student or resident interested in learning more about APMA’s governance? The APMA DEI Committee is offering three HOD Observer scholarships for students and residents to attend the APMA House of Delegates (HOD) in Washington, DC, March 14–16.

APMA submitted three comment letters in January. Two addressed potential changes in future MIPS performance years, and one was in response to the proposed rule for the 2026 CY Medicare Advantage Part D Policy.

All seven Part B MACs have delayed the effective date of their new skin substitute local coverage determinations (LCDs) until April 13 without changing any of the content of those policies.

Podiatric physicians, so long as they meet the requirements to participate in the settlement, are eligible to receive funds from the settlement. APMA is reviewing the settlement terms and will update members as appropriate.

Accurate coding is crucial for practices to ensure proper reimbursements and reduce the risk of claim denials. This seminar equips viewers with the knowledge to navigate coding complexities with confidence.

APMA’s Center for Professional Advocacy (CPA) awarded six grants in the amount of $1,000 each for the 2025 CPA Innovation Grant cycle. Components awarded include the District of Columbia, Florida, Massachusetts, Mississippi, Ohio, and South Carolina.

In December 2024, APMA submitted comments to both the Partnership for Quality Measurement (PQM) and CMS Pre-Rulemaking Measure Review Committee providing feedback regarding the Non-Pressure Ulcers episode-based cost measure currently under development.

APMA acknowledges the importance of the recently passed continuing resolution to avoid a government shutdown. However, we are profoundly disappointed that the resolution failed to address the imminent physician fee cuts under the Medicare program—a decision that leaves health-care providers across the country feeling disheartened, undervalued, and deeply concerned about their ability to sustain care for patients.

Providers impacted by the Change Healthcare cyberattack may apply for a hardship exception from MIPS participation in 2024. Additionally, CMS is applying an automatic 2024 MIPS exception to certain MIPS-eligible clinicians impacted by Hurricanes Milton, Helene, and Francine.

Take action on key items you should consider in closing out your practice in anticipation of 2025.

The 24th Annual Joint National Podiatric CAC-PIAC Representatives' Meeting took place in Alexandria, VA, on Friday, November 15. Nearly 60 volunteers from across the country came together for vital education and discussion about pressing reimbursement issues affecting you.

US Senator Bill Cassidy, MD (R-LA), a longtime champion of health care and strong supporter of podiatry, will serve as chair of the Senate Health, Education, Labor, and Pensions (HELP) Committee in the 119th Congress. This exciting news highlights a major opportunity for podiatric medicine to have its voice heard on Capitol Hill.

APMA is requesting your assistance regarding two proposed lawsuits. The first is a potential class action lawsuit regarding inappropriate denials and underpayments of claims containing Modifiers 25 and 59. The second focuses on recoupment for skin substitute products. 

On November 14, all seven Part B Medicare Contractors released final local coverage determinations (LCDs) that will govern the provision of skin substitute grafts/cellular and tissue-based products to Medicare Part B beneficiaries when used for the treatment of diabetic foot ulcers and venous leg ulcers. Following APMA advocacy and APMA's response to the initial, proposed version of this policy, there are several improvements in the final version compared to what was initially proposed. 

Complete a brief survey to help two APMA members who are conducting research into the impact of radiation exposure on the prevalence of breast and all-cause cancer in female foot and ankle surgeons.